Avadel wins FDA approval for narcolepsy drug Lumryz
Lumryz is an extended-release formulation of sodium oxybate, a central nervous system (CNS) depressant. Its therapeutic effects are believed to be mediated through GABA B actions at noradrenergic and ...
Shares of Jazz Pharmaceuticals are trading only slightly higher in the last few weeks despite two unexpected wins. Explore ...
Surgeons at a Kentucky hospital were preparing to remove the organs from a donor who had been declared dead only to realize ...
One more hurdle to clear For Avadel’s Lumryz, the one-dose extended-release oral suspension that allows narcolepsy patients to sleep through the night, the worst-case scenario is it won't be on ...
A summary of recent health news updates reveals declining Marburg cases in Rwanda, Texas suing a doctor over prescribing ...